Dynamics of the transcriptional landscape during human fetal testis and ovary development by Lecluze, Estelle et al.
1 
Dynamics of the transcriptional landscape during human fetal testis and ovary development 1 
2 
Running title: Human fetal gonad transcriptomes 3 
4 
Estelle Lecluze1, Antoine D. Rolland1, Panagiotis Filis2, Bertrand Evrard1, Sabrina Leverrier-Penna1,3, 5 
Millissia Ben Maamar1, Isabelle Coiffec1, Vincent Lavoué4, Paul A. Fowler2, Séverine Mazaud-6 
Guittot1, Bernard Jégou1, Frédéric Chalmel1,* 7 
8 
1 Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - 9 
UMR_S 1085, F-35000 Rennes, France. 10 
2 Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of 11 
Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK. 12 
3 Univ Poitiers, STIM, CNRS ERL7003, Poitiers Cedex 9, France. 13 
4 CHU Rennes, Service Gynécologie et Obstétrique, F-35000 Rennes, France. 14 
15 
* To whom correspondence should be addressed16 
Correspondence: frederic.chalmel@inserm.fr. 17 
18 






STUDY QUESTION: Which transcriptional program triggers sex differentiation in bipotential 20 
gonads and downstream cellular events governing fetal testis and ovary development in humans? 21 
SUMMARY ANSWER: The characterisation of a dynamically-regulated protein-coding and 22 
noncoding transcriptional landscape in developing human gonads of both sexes highlights a large 23 
number of potential key regulators that show an early sexually dimorphic expression pattern. 24 
WHAT IS KNOWN ALREADY: Gonadal sex differentiation is orchestrated by a sexually dimorphic 25 
gene expression program in XX and XY developing fetal gonads. A comprehensive characterisation 26 
of its noncoding counterpart offers promising perspectives for deciphering the molecular events 27 
underpinning gonad development and for a complete understanding of the aetiology of disorders of 28 
sex development in humans. 29 
STUDY DESIGN, SIZE, DURATION: To further investigate the protein-coding and noncoding 30 
transcriptional landscape during gonad differentiation, we used RNA-sequencing (RNA-seq) and 31 
characterised the RNA content of human fetal testis (N=24) and ovaries (N=24) from 6 to 17 32 
postconceptional week (PCW), a key period in sex determination and gonad development. 33 
PARTICIPANTS/MATERIALS, SETTING, METHODS: First trimester fetuses (6-12 PCW) and 34 
second trimester fetuses (13-14 and 17 PCW) were obtained from legally-induced normally-35 
progressing terminations of pregnancy. Total RNA was extracted from whole human fetal gonads and 36 
sequenced as paired-end 2x50 base reads. Resulting sequences were mapped to the human genome, 37 
allowing for the assembly and quantification of corresponding transcripts. 38 
MAIN RESULTS AND THE ROLE OF CHANCE: This RNA-seq analysis of human fetal testes 39 
and ovaries at seven key developmental stages led to the reconstruction of 22,080 transcripts 40 





displaying sex-independent differential expression during gonad development, the comparison of 42 
testes and ovaries enabled the discrimination of 13,145 transcripts that show a sexually dimorphic 43 
expression profile. The latter include 1,479 transcripts differentially expressed as early as 6 PCW, 44 
including 39 transcription factors, 40 long noncoding RNAs and 20 novel genes. Despite the use of 45 
stringent filtration criteria (expression cut-off of at least 1 fragment per kilobase of exon model per 46 
million reads mapped, fold-change of at least 2 and false discovery rate adjusted p-values of less than 47 
< 1%) the possibility of assembly artefacts and of false-positive differentially expressed transcripts 48 
cannot be fully ruled out. 49 
LARGE SCALE DATA: Raw data files (fastq) and a searchable table (.xlss) containing information 50 
on genomic features and expression data for all refined transcripts have been submitted to the NCBI 51 
GEO under accession number GSE116278. 52 
LIMITATIONS, REASONS FOR CAUTION: The intrinsic nature of this bulk analysis, i.e. the 53 
sequencing of transcripts from whole gonads, does not allow direct identification of the cellular 54 
origin(s) of the transcripts characterised. Potential cellular dilution effects (e.g. as a result of distinct 55 
proliferation rates in XX and XY gonads) may account for a few of the expression profiles identified 56 
as being sexually dimorphic. Finally, transcriptome alterations that would result from exposure to pre-57 
abortive drugs cannot be completely excluded. Although we demonstrated the high quality of the 58 
sorted cell populations used for experimental validations using quantitative RT-PCR, it cannot be 59 
totally excluded that some germline expression may correspond to cell contamination by, for example, 60 
macrophages. 61 
WIDER IMPLICATIONS OF THE FINDINGS: For the first time, this study has led to the 62 
identification of a thousand of protein-coding and noncoding candidate genes showing an early, 63 
sexually dimorphic, expression pattern that have not previously been associated with sex 64 





humans, and contribute significantly to the identification of new candidate genes involved in fetal 66 
gonad differentiation. The results also provide a unique resource that may improve our understanding 67 
of the fetal origin of testicular and ovarian dysgenesis syndromes, including cryptorchidism and 68 
testicular cancers. 69 
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Mammalian ovary and testis development is a unique process compared to other organ development, 85 
both developing from a bipotential organ which commits to a different fate following gonadal sex 86 
determination and ending up as entirely different organs. This decisive turning point guides the gonad 87 
toward one of the two developmental pathways, both including specific cell type development and 88 
proliferation. Proper differentiation of these cell lineages determines the reproductive health of the 89 
future being. In humans, the gonadal primordium arises from the thickening of the coelomic epithelium 90 
at the surface of the mesonephros around 4th postconceptional week (PCW, corresponding to 6 weeks 91 
of gestation/amenorrhea), and contains several precursor cell types, notably precursors of supporting 92 
and steroidogenic cell lineages, as well as primordial germ cells (PGC) (Wilhelm et al., 2013). The 93 
expression of the Y-linked transcription factor sex-determining region Y (SRY) during the 6th PCW in 94 
supporting cell precursors of the genital ridge triggers the expression of the SRY-box transcription 95 
factor 9 (SOX9) transcription factor which subsequently promotes a highly orchestrated gene 96 
expression program (Koopman et al., 1991; Vidal et al., 2001; Sekido and Lovell-Badge, 2008; Li et 97 
al., 2014; Rahmoun et al., 2017). These molecular events activate the commitment of Sertoli cells, 98 
leading to testis cord formation, the appearance of a fetal Leydig cell from 7 PCW onwards, and 99 
production of male hormones (androgens, insulin-like 3 protein and anti-Müllerian hormone) that are 100 
essential for embryo masculinization. In the absence of SRY the R-spondin 1 (RSPO1)/Wnt family 101 
member 4 (WNT4)/β-catenin pathway and forkhead box L2 (FOXL2) induce another complex cascade 102 
of transcriptional events, giving rise to fetal ovaries marked by the differentiation of pre-granulosa 103 
cells and the commitment of germ cells into meiosis from 10 PCW onwards (Vainio et al., 1999; 104 
Schmidt, 2004; Uda et al., 2004; Ottolenghi et al., 2007; Chassot et al., 2008; Liu et al., 2009; Le 105 
Bouffant et al., 2010; Childs et al., 2011). To ensure the appropriate commitment to a given fate, the 106 





Chang et al., 2008; Maatouk et al., 2008; Wilhelm et al., 2009; Kashimada et al., 2011; Jameson et 108 
al., 2012a; Greenfield, 2015; Bagheri-Fam et al., 2017). Sex differentiation therefore stems from a 109 
critical moment triggering a complex transcriptional landscape that governs gonad specification and 110 
organogenesis. Both male and female expression programs are highly dynamic and complex, but many 111 
blank areas remain in the map of our understanding, thus preventing full understanding of most 112 
disorders of sex development (DSDs) (Eggers et al., 2016). In particular, the noncoding counterpart of 113 
the transcriptome is likely to play critical roles in the physiology and the pathophysiology of the human 114 
developing gonads (Wu et al., 2016). 115 
Many dedicated studies have investigated in situ the gonadal expression pattern of specific human 116 
genes and/or proteins known to play important roles in sex determination or gonad development 117 
(Hanley et al., 1999, 2000; de Santa Barbara et al., 2001; Ostrer et al., 2007; Mamsen et al., 2017). In 118 
addition, several valuable genome-wide expression studies have used microarray technology to 119 
analyze whole fetal gonads (Small et al., 2005; Fowler et al., 2009; Houmard et al., 2009; Rolland et 120 
al., 2011; Munger et al., 2013; del Valle et al., 2017; Mamsen et al., 2017) or isolated fetal gonadal 121 
cell populations (Nef et al., 2005; Beverdam and Koopman, 2006; Bouma et al., 2007, 2010) in several 122 
mammalian species, including human. Recently single-cell transcriptomic analyses of thousands of 123 
cells have opened up a new window onto gonadal cell lineages during fetal life (Guo et al., 2015, 2017; 124 
Li et al., 2017; Stévant et al., 2018, 2019). Although the latest technologies hold great potential for 125 
further investigations, they are currently limited in their ability to study alternative splicing, decipher 126 
the noncoding expression program or discover novel genes (Haque et al., 2017). Alternatively, “bulk” 127 
RNA-sequencing (RNA-seq) can be used to circumvent these issues (Gkountela et al., 2015). Several 128 
landmark studies have performed RNA-seq in the mouse to investigate the transcriptome of the fetal 129 
Leydig cells (McClelland et al., 2015; Inoue et al., 2016), the regulome of the key gonadal transcription 130 





at key developmental stages (Zhao et al., 2018). Despite the limited availability of normal fetal human 132 
gonads, RNA-seq analyses of gonad development in humans represent a very precious resource for 133 
our understanding. 134 
In the present study, we performed a strand-specific, ribo-depleted RNA sequencing approach to 135 
unravel the protein-coding and noncoding transcriptional landscape of human developing fetal testes 136 
and ovaries from 6 to 17 PCW. Selected time-points were chosen to encompass the time window from 137 
early transcription of the SRY gene in the male to differentiation and primary sex-specific control of 138 
the cell lineages in both gonads. This analysis allowed us to identify a complex sexually and non-139 
sexually dimorphic expression program driving gonad development, with a focus on non-coding genes 140 
as well as new unannotated genes that had not previously been described. In particular we have 141 
highlighted a core set of transcripts showing a sex-biased expression after the onset of SRY expression 142 
within the whole gonad during the 6th PCW that likely plays a critical role in fetal gonad differentiation, 143 
and potentially for sex determination in humans. Our study significantly expands knowledge of human 144 
gonadogenesis and provides a rich source of data for geneticists and clinicians working in the field of 145 





Materials and Methods 147 
Ethical considerations and sample collection 148 
First trimester fetuses  149 
Human fetuses (8-14 GW) were obtained from legally-induced normally-progressing terminations of 150 
pregnancy performed in Rennes University Hospital. Tissues were collected with women’s written 151 
informedconsent, in accordance with the legal procedure agreed by the National Agency for 152 
Biomedical research (#PFS09-011) and the approval of the Local ethics committee of Rennes Hospital 153 
(# 11-48). The termination of pregnancy was induced using a standard combined mifepristone and 154 
misoprostol protocol, followed by aspiration. Gestational age was determined by ultrasound, and 155 
further confirmed by measurement of foot length for mathematical estimation of fetal development  156 
(Evtouchenko et al., 1996; O’Shaughnessy et al., 2019). The gonads were recovered and dissected free 157 
of mesonephros in ice-cold phosphate-buffered saline (PBS) using a binocular microscope (Olympus 158 
SZX7, Lille, France). The sex of the gonad was determined by morphological criteria, except for 159 
fetuses younger than 7 PCW, for which a PCR was performed on genomic DNA using primers specific 160 
for SRY (ACAGTAAAGGCAACGTCCAG; ATCTGCGGGAAGCAAACTGC) (Friel et al., 2002) 161 
as well as for amelogenin X-linked (AMELX) and amelogenin Y-linked (AMELY) 162 
(CTGATGGTTGGCCTCAAGCCTGTG; GTGATGGTTGGCCTCAAGCCTGTG) (Akane et al., 163 
1992). 164 
 165 
Second trimester fetuses  166 
Human fetuses (13-14 and 17 PCW) were obtained from pregnant women after legally induced 167 
abortions at the Aberdeen Pregnancy Counselling Service. The collection of fetal material was 168 





04/S0802/21). In all cases, women seeking elective terminations of pregnancy were recruited with full 170 
written, informed consent by nurses working independently of the study at the Aberdeen Pregnancy 171 
Counselling Service. Maternal data and medications used were recorded. Only fetuses from normally 172 
progressing pregnancies (determined at ultrasound scan prior to termination) from women over 16 173 
years of age were collected following termination induced by a standard combined mifepristone and 174 
misoprostol protocol, as detailed previously (O’Shaughnessy et al., 2007; Fowler et al., 2008). Fetuses 175 
were transported to the laboratory within 30 min of delivery, weighed, sexed and the crown-rump 176 
length recorded. Fetal tissues were snap-frozen in liquid nitrogen and stored at -80°C. 177 
 178 
RNA extraction, library construction and RNA-sequencing 179 
Total RNA was extracted from human fetal gonads using the RNeasy mini Kit (Qiagen, Hilden, 180 
Germany), quantified using a NanoDrop™ 8000 spectrophotometer (Thermo Fisher Scientific, 181 
Waltham, MA, USA) and quality controlled using a 2100 Electrophoresis Bioanalyzer (Agilent 182 
Technologies, Santa Clara, CA, USA). Only RNA extracts with a high quality RNA integrity number 183 
(average value = 9.8 - ranging from 8.6 to 10) were included. Libraries suitable for strand-specific high 184 
throughput DNA sequencing were then constructed, essentially as previously described (Jégou et al., 185 
2017; Rolland et al., 2019) using “TruSeq Stranded Total RNA with Ribo-Zero Gold Prep Kit” 186 
(catalog # RS-122-2301, Illumina Inc., San Diego, CA, USA). The libraries were finally loaded in the 187 
flow cell at 7 pM concentration and clusters were generated in the Cbot and sequenced in the Illumina 188 
Hiseq 2500 as paired-end 2x50 base reads following Illumina's instructions. Image analysis and base 189 






Read mapping, transcript assembly and quantification with the Tuxedo suite 192 
Assembly of a unique set of human reference transcripts  193 
Ensembl (Yates et al., 2016) and RefSeq (Pruitt et al., 2014; Brown et al., 2015) transcript annotations 194 
(GTF format) of human genome (release hg19) were downloaded from the UCSC (Speir et al., 2016) 195 
in June 2015, and were merged with Cuffcompare (Pollier et al., 2013). This non-redundant annotation 196 
was then used as the human reference transcripts (HRT) as previously published (Chalmel et al., 2014). 197 
A non-redundant dataset of human splice junctions (HSJ) was also extracted from alignments of human 198 
transcripts and expressed sequence tags on the human genome as provided by UCSC. 199 
Read mapping 200 
Reads from each individual sample were aligned to the hg19 release of the human genome with 201 
TopHat2 (version 2.0.12) (Trapnell et al., 2012) using previously published approaches (Pauli et al., 202 
2012; Trapnell et al., 2012; Chalmel et al., 2014; Zimmermann et al., 2015). Briefly, TopHat2 program 203 
was first run for each fastq file, using HRT and HSJ datasets to improve read mapping. Exonic junction 204 
outputs were then merged and added to the HSJ set. TopHat2 was next run a second time using the 205 
new HSJ dataset to produce a final alignment file (BAM format) for each. Finally, BAM files 206 
corresponding to the same experimental condition (fetal testes or ovaries, at a given time-point) were 207 
merged and sorted with the Samtools suite (version 2.19.0) (Li et al., 2009). 208 
Transcriptome assembly and quantification 209 
The Cufflinks suite (version 2.2.1, default settings) (Pollier et al., 2013) was used to assemble 210 
transcript fragments (or transfrags) for each experimental condition based on merged BAM files. 211 
Resulting assembled transcripts were further merged into a non-redundant set of transfrags which were 212 
further compared to the HRT dataset with the Cuffcompare program. Finally, Cuffquant was used to 213 





model per million reads mapped (FPKM), and the normalization of the expression values across 215 
samples was performed by Cuffnorm. 216 
Refinement of assembled transcripts 217 
A four-step strategy was used to filter out dubious transcripts as previously described (Prensner et al., 218 
2011; Chalmel et al., 2014) (Fig. S1). First, based on the Cuffcompare comparison, we only selected 219 
transfrags defined as complete match (‘=’), potentially novel isoform (‘j’), falling entirely within a 220 
reference intron (‘i’) or an intergenic region (‘u’), or showing exonic overlap with reference on the 221 
opposite strand (‘x’). Next, assembled transcripts of less than 200 nucleotides or that were undetectable 222 
(<1 FPKM) were discarded. Finally, all transfrags that were annotated as either novel isoforms or novel 223 
genes (class codes “j”, “i”, “u” or “x”) and that did not harbor at least two exons (multi-exonic) were 224 
filtered out. 225 
Principal component analysis 226 
Principal component analysis (PCA) was performed based on the expression values of refined 227 
transcripts with the FactoMineR package to graphically evaluate the distribution of sequenced samples 228 
(Lê et al., 2008). 229 
 230 
Coding potential analysis of assembled transcripts 231 
DNA sequences of the refined transcripts were extracted with TopHat’s gffread tool. As recommended 232 
in (Chocu et al., 2014; Zimmermann et al., 2015), the protein-coding potential of each transcript was 233 
estimated with an empirical integrative approach based on four predictive tools: Coding-Potential 234 
Assessment Tool (CPAT, coding probability > 0.364) (Wang et al., 2013), HMMER (E-value < 10-4) 235 
(Finn et al., 2011), Coding Potential Calculator (CPC, class “coding”) (Kong et al., 2007) and 236 





encode for proteins if their nucleic sequences were considered as protein-coding by at least two 238 
predictive tools. 239 
 240 
Proteomics informed by transcriptomics strategy 241 
As previously published in (Chocu et al., 2014; Rolland et al., 2019), we made use of a Proteomics 242 
Informed by Transcriptomics (PIT) approach (Evans et al., 2012) to provide evidence at the protein 243 
level for assembled transcripts. First, we assembled a customized non-redundant protein database by 244 
merging the UniProt (Pundir et al., 2015) and the Ensembl (Yates et al., 2016)(downloaded 2015/10) 245 
proteome databases together with the set of predicted proteins derived from the assembled transcripts. 246 
Briefly, the refined transcript sequences were translated into the three-first open reading frames with 247 
the EMBOSS’s Transeq program (Rice et al., 2000) and only the amino acid sequences of at least 20 248 
residues were selected. 249 
We next made use of the human fetal gonad MS/MS proteomics datasets available from the Human 250 
Proteome Map (Kim et al., 2014). First, 131 raw data files (corresponding to three fetal ovary samples 251 
and two fetal testis samples) were downloaded from the PRIDE database (accession number 252 
PXD000561) (Vizcaíno et al., 2016) and converted into mgf format with ProteoWizard (Adusumilli 253 
and Mallick, 2017). Subsequent analyses were performed with SearchGUI (Vaudel et al., 2011) 254 
(version 3.2.20) and PeptideShaker (Vaudel et al., 2015)(version 1.16.8). A concatenated target/decoy 255 
database was created from the enriched reference proteome with SearchGUI. Cross-peptide 256 
identification was then performed with X!Tandem, Open Mass Spectrometry Search Algorithm 257 
(OMSSA), and MSGF+ tools, with these following parameters: precursor ion tolerance units set at 10 258 
ppm; fragment tolerance set at 0.05 Da; carbamidomethylation of cysteine defined as a fixed 259 





modification; only tryptic peptides with up to two missed cleavages; and minimum peptide length set 261 
to six amino acids. All peptides with at least one validated peptide spectrum match (PSM) and a 262 
confidence score greater than 80% with PeptideShaker, were kept for further analyses. Finally, only 263 
identifications with a false discovery rate (FDR) <1% were selected. 264 
 265 
Statistical transcript filtration 266 
The set of sexually dimorphic transcripts (SDTs) was defined by filtering transfrags that exhibited a 267 
≥ 2-fold difference between the male and female gonads (using median expression values of sample 268 
replicates) in at least one of the seven developmental stages. A Linear Models for Microarray Data 269 
(LIMMA) statistical test was then used to identify transcripts displaying significant changes between 270 
male and female gonads (F-value adjusted with a FDR ≤ 5%) (Smyth, 2004). Among SDTs, those 271 
showing a differential expression as early as 6 PCW were designated as the set of early SDTs (or early-272 
SDTs). In addition, the set of developmental regulated transcripts (DRTs) were also selected by 273 
isolating transfrags that exhibited a ≥ 2-fold difference between two developmental stages during 274 
either male or female gonad development. Similar to the selection of SDTs, a F-value adjusted with a 275 
FDR ≤ 5% was then used to identify candidates showing significant variations across developmental 276 
stages. Finally, the difference between the sets of DRTs and SDTs allowed us to discriminate non-277 
sexually dimorphic transcripts (NSDTs) corresponding to the set of transfrags showing a 278 
developmentally regulated expression pattern across fetal gonad development, but no significant 279 






Cluster and functional analyses 282 
The resulting SDTs and NSDTs were then clustered into fourteen (named P1-14) and six (Q1-6) 283 
expression patterns with the unsupervised hierarchical clustering on principle components (HCPC) 284 
algorithm, respectively (Lê et al., 2008). These clusters were then ordered according to peak expression 285 
levels across developmental stages in testes first and then ovaries. Gene Ontology (GO) term 286 
enrichments were estimated with the Fisher exact probability, using a Gaussian hypergeometric test 287 
implemented in the Annotation Mappin Expression and Network suite (AMEN) (Chalmel and Primig, 288 
2008). A GO term was considered significantly associated with a given expression pattern if the FDR-289 
corrected P value was ≤5% and the number of genes bearing this annotation was ≥5. 290 
 291 
Transcription factors and their related target genes 292 
To get an insight into potentially important regulators that might be involved in early human gonad 293 
development or sex determination, transcriptional factors and their targets were extracted from public 294 
databases, the Transcriptional Regulatory Relationships Unraveled by Sentence-based Text mining 295 
database (TRRUST) (Han et al., 2015) and Transcription Factor encyclopedia (Yusuf et al., 2012). 296 
 297 
FACS sorting and quantitative PCR validation 298 
Single cell dissociation and cell sorting 299 
Single cell suspensions were obtained from gonads by a standard enzymatic and mechanic digestion 300 
procedure. Gonads were cut into small pieces and digested in 0.25% Trypsin-0.02% EDTA (#T4049, 301 
Sigma-Aldrich) and 0.05 mg/ml DNase (#DN25, Sigma-Aldrich, Missouri, USA) for 10 min at 37 °C. 302 





centrifuged at 350 g for 5 min at 37°C. Dispersed cells were resuspended in PBS and counted on a 304 
Malassez hemocytometer after labeling of dead cells with Trypan blue. For testes, a plasma membrane 305 
labelling of cord cells was performed using a mouse FITC-conjugated anti-human epithelial antigen 306 
(clone Ber EP4; Dako # F0860, diluted 1:100) associated with a labelling of germ cells with a mouse 307 
R-Phycoerythrin-coupled anti-human KIT proto-oncogene, receptor tyrosine kinase (KIT/CD117) 308 
(clone 104D2, BioLegend, San Diego, CA, USA, # 313204, diluted 1:100) for 30 min at room 309 
temperature. For ovaries, germ cells were labeled with the mouse R-Phycoerythrin-coupled anti-310 
human KIT/CD117 as described above. Cells were sorted by a flow cytometer cell sorter FACSAriaII 311 
(BD Biosciences, New Jersey, USA) equipped with Diva software. Cells were collected in PBS, 312 
centrifuged at 500g for 45 min at 4°C and pelleted cells were stored at -80°C until RNA extraction. 313 
 314 
Quantitative RT-PCR 315 
RNA was extracted from cell pellets with PicoPure RNA Isolation Kit (Thermo Fisher Scientific) 316 
according to manufacturer’s instructions. Total RNAs (100 ng) were reverse transcribed with iScript 317 
cDNA synthesis kit (Biorad, Hercules, CA, USA) and quantitative PCR was performed using the 318 
iTaq© universal SYBR green supermix (Biorad) according to manufacturer’s instructions in a Cfx384 319 
OneTouch Real-Time PCR system (Biorad). The following amplification program was used: an initial 320 
denaturation of 3 min at 95°C, 40 cycles of 10 sec denaturation at 95°C and 30 sec at 62°C for annealing 321 
and extension. Dissociation curves were produced using a thermal melting profile performed after the 322 
last PCR cycle. Primer pairs flanking introns were designed in order to avoid amplification of 323 
contaminating genomic DNA whenever possible and they were aligned onto human RefSeq transcripts 324 
using primer-BLAST to check for their specificity. Furthermore, only those primers that produced a 325 
single peak  during the melting curve step (i.e. with peak temperature variance of no more than 0.5°C) 326 





I). Ribosomal protein lateral stalk subunit P0 (RPLP0) and ribosomal protein S20 (RPS20) mRNA, 328 
used as internal controls for normalization purposes, were initially validated in human adult testis 329 
gonad (Svingen et al., 2014) and further used for human fetal gonads (Jørgensen et al., 2018). Results 330 
were calculated with Bio-Rad CFX Manager 3.1 using the ΔΔCT method as n-fold differences in target 331 
gene expression, relative to the reference gene and calibrator sample, which comprises an equal 332 
mixture of all the tested samples for a given organ. 333 
 334 
Immunohistochemistry and immunofluorescence 335 
Upon collection, additional gonads (seven testes and five ovaries) were fixed either in Bouins fluid 336 
fixative or paraformaldehyde 4% (w/v) for 1 to 2 hours, embedded in paraffin using standard 337 
procedures and cut into 5 µm-thick sections. After dewaxing and rehydration, slides were treated for 338 
antigen retrieval with pre-heated 10 mM citrate buffer, pH 6.0 at 80°C for 40 min before cooling at 339 
room temperature . Sections were blocked for 1 h at room temperature with 4% bovine serum albumin 340 
in PBS before the overnight incubation at 4°C with the primary antibody diluted in Dako antibody 341 
diluent (Dako Cytomation, Trappes, France). Antibodies and conditions are described in Table II. 342 
Secondary antibodies were goat anti-rabbit biotinylated antibody (E0432, Dako, diluted 1:500); or 343 
rabbit anti-mouse biotinylated antibody (E0464, Dako, diluted 1:500). Sections were developed with 344 
streptavidin-horseradish peroxidase (Vectastain ABC kit, Vector Laboratories, Burlingame, CA, USA) 345 
and 3,3’-diaminobenzidine tetrahydrochloride (Vector Laboratories Inc.) and counterstained with 346 
hematoxylin. Stained sections were examined and photographed under light microscopy (Olympus 347 
BX51). For cryosectioning, additional paraformaldehyde-fixed gonads were cryopreserved in PBS-348 
sucrose 20%, embedded in NEG50TM (Allan-Richard Scientific, Thermo Fisher Scientific) and cut in 349 





described, when necessary (for WT1 transcription factor, WT1; neurexin 3, NRXN3; contactin 1, 351 
CNTN1; and lin-28 homolog A, LIN28), rinsed in PBS and incubated overnight at 4°C with primary 352 
antibody. Rinsed sections were incubated with the ad hoc fluorescent secondary antibodies (1:500). 353 
The second primary antibody was subsequently incubated overnight at 4°C followed by the 354 
corresponding secondary antibody. Secondary antibodies were either 488 or 594 Alexa Fluor 355 
conjugated antibodies made in chicken for rabbit- and mouse-hosted primary antibodies, and in donkey 356 
for Contactin 1 (CNTN1) primary antibody (Invitrogen). Sections were mounted in prolong Gold anti-357 
fade reagent with DAPI (Invitrogen, Carlsbad, CA, USA; Thermo Fisher Scientific). Slides were 358 
examined and photographed with an AxioImager microscope equipped with an AxioCam MRc5 359 
camera and the ZEN software (Zeiss, Le Pecq, France). 360 






Expression profiling of fetal gonads identifies more than 300 new genes in the human genome 363 
To investigate the expression program governing gonad differentiation in humans, we performed a 364 
RNA-seq analysis on fetal testes (n=24) and ovaries (n=24), covering seven developmental stages 365 
from 6 to 17 PCW (i.e. from 8 to 19 gestational weeks) (Fig. 1A). Following read mapping and 366 
transcript reconstruction (Supplementary Table SI), a stringent refinement strategy selected a “high-367 
confidence” set of 35,194 transcripts expressed in human fetal gonads (Supplementary Fig. S1). A 368 
PCA of these expression data provided a first hint on the biological relevance of our dataset: The first 369 
three components indeed appeared strongly correlated with the developmental stage (dimensions 1 and 370 
3) and the genetic sex (dimension 2) of samples (19.7% and 15.3% of variance, respectively) (Fig. 1B 371 
and C). A hierarchical clustering based on the 35 first PCA dimensions explaining 90% of the total 372 
variance of the data further confirms the reliable distribution of the samples according to the sex and 373 
the developmental stage (Fig. 1D). 374 
The comparison of reconstructed transcripts with RefSeq and Ensembl reference annotations identified 375 
known (13,673; 38.9%) and novel (18,718; 53.2%) isoforms of annotated protein-coding genes as well 376 
as known (529, 1.5%) and novel (680, 1.9%) isoforms of annotated long noncoding RNAs (lncRNAs). 377 
Importantly this comparison also identified 318 novel unannotated transcripts (NUTs) corresponding 378 
to new intronic (81, 0.2%), intergenic (164, 0.5%) or antisense (73, 0.2%) as yet uncharacterized genes 379 
in the human genome. The comparison of genomic and expression features highlighted significant 380 
differences between mRNAs, lncRNAs and NUTs (Supplementary Fig. S2). As expected, lncRNAs 381 
are expressed at lower levels than mRNAs, are more specifically expressed during single stages of 382 
development, and have lower sequence conservation, length, number of exons and GC content. 383 





conservation, length, number of exons and GC content as well as a more restricted expression than 385 
lncRNAs and mRNAs (Supplementary Fig. S2). 386 
We next combined results from a coding potential analysis and from a proteomics informed by 387 
transcriptomics approach (PIT) (Evans et al., 2012) to characterize the protein-encoding potential of 388 
novel isoforms and loci identified above. As expected, 98.5% of mRNAs (known and novel isoforms) 389 
displayed a high protein-encoding potential, and 56% of them were supported at the protein level 390 
thanks to at least one identified peptide (Fig. 1E). On the other hand, only 48.1% of lncRNAs (known 391 
and novel isoforms) were predicted to have a high protein-encoding potential (PEP), and as little as 392 
8.5% were identified during the PIT analysis, usually through a single peptide identification (Fig. 1E). 393 
When NUTs were finally evaluated, they mostly displayed features similar to lncRNAs: 76.1% of them 394 
were predicted to have a low protein-encoding potential while only 0.4% were confirmed at the protein 395 
level (Fig. 1E). Besides, 94 lncRNAs (including 53 with two or more peptides identified) and one NUT 396 
were both predicted to have a high protein-encoding potential and demonstrated at the protein level. 397 
 398 
Transcriptome dynamics during human gonad development define sexually and non-sexually 399 
dimorphic expression programs 400 
We next focused on genes with dynamic expression patterns during gonad development. Several steps 401 
of statistical filtration led to the selection of 13,145 transcripts (7,633 genes) that were differentially-402 
expressed between testes and ovaries (called SDT), most of which (10,521 transcripts, 6,587 genes) 403 
were also developmentally-regulated (Fig. 1F). Notably, 8,935 transcripts (5,961 genes) were 404 
differentially-expressed during gonad development but did not show significant difference between 405 





We further classified SDT into 14 clusters (termed P1-P14) according to their preferential expression 407 
pattern (Fig. 2A and B). Patterns P1-P7 include transcripts showing peak expression in fetal testes at 408 
6 to 7 PCW (P1; SRY; doublesex and mab-3 related transcription factor 1,DMRT1), at 7 PCW (P2; 409 
SOX9, desert hedgehog signalling molecule, DHH; inhibin subunit beta B, INHBB), at 9 to 12 PCW 410 
(P4; cytochrome P450 family 11 subfamily A member 1, CYP11A1; cytochrome P450 family 17 411 
subfamily A member 1, CYP17A1; steroidogenic acture regulatory protein, STAR; luteinizing 412 
hormone/choriogonadotropin receptor, LHCGR; insulin like 3, INSL3), at 13 to 17 PCW (P6; actin 413 
alpha 2, ACTA2; prostaglandin D2 synthase, PTGDS) or with a broader expression pattern throughout 414 
testis development (P3; nuclear receptor subfamily 5 group A member 1, NR5A1; nuclear receptor 415 
subfamily 0 group B member 1, NR0B1; and P5; WT1 transcription factor, WT1; claudin 11 CLDN11). 416 
Similarly, transcripts belonging to patterns P8-P14 are preferentially expressed in fetal ovaries and 417 
display peak expression at 7 PCW (P8; RPSO1, anti-Mullerian hormone receptor type 2, AMHR2; 418 
nanog homeobox, NANOG), at 7-9 PCW (P9; POU class 5 homeobox 1, POU5F1; developmental 419 
pluripotency associated 2 and 4, DPPA2/4; lin-29 homolog A and B, LIN28A/B), at 12 PCW (P11; 420 
FOXL2, deleted in azoospermia like, DAZL; piwi like RNA-mediated gene silencing 2, PIWIL2), at 421 
13-14 PCW (P12; MET proto-oncogene, receptor tyrosine kinase, MET; delta like canonical Notch 422 
ligand 4, DLL4; X inactive specific transcript, XIST; vascular endothelial growth factor A, VEGFA), 423 
at 17 PCW (P13; meiotic double-stranded break formation protein 1, MEI1; meiosis specific with OB-424 
fold, MEIOB; SPO11 initiator of meiotic double stranded breaks, SPO11; synaptonemal complex 425 
protein 1 to 3, SYCP1-3; and P14; folliculogenesis specific bHLH transcription factor, FIGLA; 426 
NOBOX oogenesis homeobox, NOBOX; spermatogenesis and oogenesis specific basic helix-loop-427 
helix 1, SOHLH1) or with a broader expression throughout ovarian development (P10; DNA meiotic 428 
recombines 1, DMC1; empty spiracles homeobox 2, EMX2; lymphoid enhancer binding factor 1 429 





patterns by a GO term enrichment analysis (Fig. 2C). Several broad biological processes related to 431 
organogenesis and/or cell differentiation were enriched in various testis-associated (P1, P2, P5, P6) 432 
and ovary-associated (P8) patterns. More precisely, expression pattern P4 was found to be enriched in 433 
genes involved in steroidogenesis while several processes associated with meiosis and female germ 434 
cell development were found to be enriched in P13 and P14, which is consistent with the differentiation 435 
and development of Leydig cells in fetal testes from 7 PCW onwards and with the commitment of 436 
ovarian germ cells into meiosis from 12 PCW onwards, respectively. Finally, we investigated the 437 
distribution of RNA biotypes and found that lncRNAs and NUTs were significantly enriched in 438 
expression patterns P12 to P14 (Fig. 2D). 439 
The 8,935 NSDTs were also classified according to peak expression into six expression patterns 440 
(termed Q1-Q6) and include transcripts expressed at early stages of gonad differentiation (6-7 PCW; 441 
Q1 and Q2; including WT1, GATA binding protein 4, GATA4), following sexual differentiation (7-9 442 
PCW; Q3 and Q4; DMRT1, SRY-box transcription factor 8, SOX8) or at later stages of gonad 443 
development (12-17 PCW; Q5 and Q6; nuclear receptor subfamily 6 group A member 1, NR6A1) (Fig. 444 
3A-C). Finally, when investigating the distribution of RNA biotypes within co-expression groups, we 445 
found that lncRNAs and NUTs were enriched in expression patterns Q1 and Q6 (Fig. 3D). While these 446 
transcripts are also likely to include factors with important roles during gonadal differentiation and 447 
development, they were not further investigated in this study. All data, however, are available through 448 
the ReproGenomics Viewer (RGV) genome browser (http://rgv.genouest.org/) (Darde et al., 2015, 449 
2019) and are also available as a searchable table (.xlss) containing information on genomic features 450 







A complex transcriptional program governing early gonadal differentiation 454 
In order to highlight new candidate genes that could be involved in early gonadal differentiation, we 455 
focused our analysis on 1,479 SDTs showing a significant differential expression in fetal gonads as 456 
early as 6 PCW (Supplementary Fig. S3). Most of these early-SDTs (61.7%) logically belong to early 457 
expression patterns P1, P2, P8 and P9. This set of genes is composed of important actors including 458 
SRY (P1), SOX9, DHH, patched 1 (PTCH1) and cytochrome P450, family 26 subfamily b polypeptide 459 
1 (CYP26B1) (P2), LIM homeobox 9 (LHX9) (P6), activin A receptor type 1B (ACVR1B) (P8), AMHR2 460 
(P9) or FOXL2 (P11) which demonstrates the relevance of this filtration for selecting important factors 461 
in sex differentiation (Supplementary Fig. S3B and S3C). In addition to well-known transcription 462 
factors, such as SRY, SOX9, LHX9, or FOXL2, 174 early SDTs correspond to 131 genes encoding 463 
transcriptional regulators that should also play a critical role in the establishment of this complex 464 
sexually dimorphic expression program (Supplementary Table SII). Although the proportion of early-465 
SDTs in the distinct expression patterns P1-P14 according to their coding status are generally similar 466 
to those of SDT (Supplementary Fig. S3D), it is important to note that this set of candidates includes 467 
40 lncRNAs and 20 NUTs which may be involved in early steps of gonad differentiation. 468 
 469 
Distinct cellular expression patterns of newly identified genes involved in human sex determination 470 
 471 
To investigate further the cellular origin of selected candidates, we performed immunohistochemistry 472 
experiments as well as quantitative PCR (qPCR) on FACS-sorted cells. The successful enrichment of 473 
Sertoli cells (hEpA+/KIT-), germ cells (KIT+) and interstitial cells (hEpA-/KIT-) from 6–7 PCW testes 474 
was notably validated by the expression of SOX9, KIT proto-oncogene, receptor tyrosine kinase (KIT) 475 





C), while that of germ cells (KIT+) and somatic cells (KIT-) from 6–8 PCW and 10–12 PCW ovaries 477 
was confirmed by the high expression levels of KIT, FOXL2 or NR2F2, respectively (Supplementary 478 
Fig. S4D-F). We first investigated genes that display expression profiles similar to that of SRY (P1; 479 
high expression and clear sexual dimorphism in 6 PCW testes), such as Wnt ligand secretion mediator 480 
(WLS), C-X-C motif chemokine ligand 14 (CXCL14) and C-C motif chemokine receptor 1 (CCR1) 481 
(Fig. 4A). While WLS was mainly expressed in Sertoli cells it was also substantially expressed in 482 
interstitial cells, whereas CXCL14 was only expressed in Sertoli cells (Fig. 4A). In contrast, the 483 
expression of CCR1 was mainly detected in germ cells. We also analysed genes with an expression 484 
profile similar to SOX9 (P2; clear sexual dimorphism and peak of expression in 7 PCW testes), such 485 
as EPH receptor B1 (EPHB1), fetal and adult testis expressed 1 (FATE1), MAGE family member B1 486 
(MAGEB1), erb-b2 receptor tyrosine kinase 3 (ERBB3), Cbp/p300 interacting transactivator with 487 
Glu/Asp rich carboxy-terminal domain 1 (CITED1) and a NUT antisense to CITED1 488 
(TCONS_00249587) (Fig. 4B). We found that EPHB1, FATE1, MAGEB1 and ERBB3 were indeed 489 
expressed in Sertoli cells and to a lesser extent in interstitial cells, while SRY-box transcription factor 490 
10 (SOX10) was expressed at similar levels in Sertoli cells and interstitial cells (Fig. 4B). Interestingly, 491 
we found that both CITED1 and its potential antisense RNA were specifically and simultaneously 492 
expressed in Sertoli cells. Consistently with qPCR results, SOX10, EPHB1, MAGEB1, and FATE1 493 
proteins were indeed all found in cord cells at the histological level, but exhibited varying ratios of 494 
expression in Sertoli and germ cells (Fig. 4C). For instance, SOX9 was expressed only in Sertoli cells, 495 
whereas MAGEB1 was clearly expressed in germ cells as well. 496 
We also investigated the cell distribution of genes preferentially expressed in ovary (P8-P9) (Fig. 5A-497 
D). First, several of them show a higher differential expression as early as 6 PCW, and were 498 
preferentially expressed in somatic cells, including neurexin 3 (NRXN3), contactin 1 (CNTN1) and 499 





TCONS_00153406 (Fig. 5A). In agreement, immunolabeling showed NRXN3 protein in the nucleus 501 
of cells surrounding KIT+ germ cells, with a pattern very similar to that of WT1 (Fig. 5D). 502 
Interestingly, CNTN1 protein was found in a subset of epithelial cells surrounding LIN28+ germ cells 503 
in 6 PCW ovaries, or in ovarian cords adjacent to the mesonephric-gonadal junction (Fig. 5D) but not 504 
in the surface epithelium. Several genes show higher levels of differential expression at later stages in 505 
gonad development (Fig. 5B-C). Some of those genes, such as neuropeptide Y (NPY), SRY-box 506 
transcription factor 4 (SOX4) and the novel transcript TCONS_00224470, were preferentially 507 
expressed in somatic cells, as was RSPO1 (Fig. 5B). In contrast, others displayed patterns typical of 508 
germline-associated expression patterns, including POU5F1 (a well-known germ cell marker) and 509 
three NUTs, TCONS_00113718, TCONS_00055038 and TCONS_00042565, which were highly 510 






Unravelling the molecular sequence of events involved in gonadogenesis and sex determination is 513 
essential in order to understand DSDs. Although a significant number of studies have already examined 514 
the sexually dimorphic expression program driving gonad development in animal models (Beverdam 515 
and Koopman, 2006), its characterization remains elusive in humans. Three studies have investigated 516 
the transcriptome of the developing gonads from 5.7 to 10 PCW (Mamsen et al., 2017; del Valle et al., 517 
2017) and of ovarian primordial follicle formation from 13 to 18 PCW (Fowler et al., 2009) in humans. 518 
However, they were based on microarray technologies, thus restricting the gene set studied and limiting 519 
the characterization of non-coding transcripts and the identification of new genes. Our study is among 520 
the first to capitalize on the power of the “bulk” RNA-seq technology to perform an in-depth 521 
characterization of the dynamic transcriptional landscape of whole human fetal gonads, from early 522 
differentiation (i.e. 6 PCW) up to Leydig cell transition in the testis and primary follicle formation in 523 
the ovary (i.e. 17 PCW), at both the protein-coding and non-coding levels. In particular our results 524 
identify transcriptional regulators, lncRNAs and novel genes (NUTs) that show an early sexually 525 
dimorphic expression pattern and could therefore play important regulatory roles from sex 526 
determination onwards. Nevertheless, as in any model, including animals that are sacrificed with 527 
anesthesia or CO2 or in the case of spontaneous abortions where the development of the embryo or 528 
foetus can be disturbed, it should be borne in mind that there is a small chance that some transcriptional 529 
alterations might result from exposure to pre-abortive drugs. Collectively this work constitutes a rich 530 
resource for the community by providing new information regarding the early molecular events that 531 
could be involved in both normal sex differentiation and DSDs. 532 
Our study confirms and complements previous findings accumulated in humans and other species (Nef 533 
et al., 2005; Beverdam and Koopman, 2006; Jameson et al., 2012b; Zhao et al., 2018; Planells et al., 534 





PCW in (Mamsen et al., 2017)) but also demonstrates the over-expression of SOX9 in the testis as 536 
early as 6 PCW (previously reported at only 6.8 PCW in (Mamsen et al., 2017)), which may reflect 537 
the higher sensitivity of RNA-seq as compared to microarrays (Mantione et al., 2014). Altogether our 538 
transcriptional profiling allowed us to identify over 33,000 transcripts expressed in human developing 539 
fetal gonads, including mRNAs and lncRNAs as well as unknown genes. Although our analysis was 540 
mostly focused on SDTs, a set of almost 9,000 transcripts showing similar expression profiles in testes 541 
and ovaries (NSDTs) was also identified despite major cell composition differences between the two 542 
gonad types, especially at later developmental stages. These transcripts therefore represent valuable 543 
information on critical molecular factors underlying or required for the development of both XX and 544 
XY gonads, including for instance WT1 and its multiple isoforms required at different stages (Hastie, 545 
2017). 546 
We then focused our analysis on 1,479 SDTs showing sexual dimorphism as early as 6 PCW, including 547 
more than 1,000 candidate genes that have not previously been associated with sex differentiation. It 548 
is noteworthy that most of these early dimorphic profiles are likely to result from true differential 549 
transcriptional regulation rather than from dilution effects, as the cell composition of XX and XY fetal 550 
gonads at this stage remains highly analogous. To further highlight new promising candidates that 551 
might be involved in the regulation of this complex expression program we next focused on the 131 552 
genes encoding transcription factors and showing an early SDT pattern (Supplementary Table SII). 553 
Among them, the cAMP responsive element modulator (CREM), a well-known regulator of gene 554 
expression programming of post-meiotic germ cells in the adult testis (Hogeveen and Sassone-Corsi, 555 
2006), is preferentially expressed in XY gonads at 6 PCW. We also found that one of its target genes, 556 
the tachykinin precursor 1 (TAC1) (Qian et al., 2001), is over-expressed in the fetal ovary at this early 557 
developmental stage suggesting that CREM might negatively regulate TAC1 in the human fetal testis. 558 





belonging to the tachykinin family that are critical for many biological processes (Dehlin and Levick, 560 
2014; Sun and Bhatia, 2014; Sorby-Adams et al., 2017). GLI family zing finger 1 (GLI1) is also an 561 
interesting candidate as it is preferentially expressed in the fetal testis as early as 6 PCW (Mamsen et 562 
al., 2017) and encodes a transcription factor known to regulate the expression of the secreted frizzled 563 
related protein 1 (SFRP1) (Kim et al., 2010). Since SFRP1 is critical for fetal testis development in 564 
the mouse (Warr et al., 2009), acting through its suppression of Wnt signalling (Kim et al., 2010), this 565 
could suggest a potential important role for both GLI1 and SFRP1 during sex differentiation in humans. 566 
Mamsen and collaborators deduced from their microarray experiment that the onset of steroidogenesis 567 
in male gonads occurred at 7.5 PCW (Mamsen et al., 2017). We also consistently found that the 568 
expression of genes involved in steroidogenesis increased drastically in testes from 7 PCW onwards. 569 
However, several genes, such as CYP17A1, CYP11A1, hydroxy-delta-5-steroid dehydrogenase, 3 beta- 570 
and steroid delta-isomerase 2 (HSD3B2) and hydroxysteroid 17-beta dehydrogenase 3 (HSD17B3), 571 
actually exhibited sexual dimorphism as early as 6 PCW, suggestive of an earlier induction of the 572 
molecular networks underlying Leydig cell differentiation. A more likely explanation could be that 573 
even if they are expressed only in Leydig cells later in development, (pre-)Sertoli cells may also 574 
express such factors in early stages. This would be in line with the described co-operation between 575 
these two cell types for the synthesis of androgens in the mouse fetal testis (O’Shaughnessy et al., 576 
2000; Shima et al., 2013) at 6 PCW. Among male-biased early-SDTs we also identified expression 577 
patterns similar to that of SRY, such as for the Wnt ligand secretion mediator (WLS) and for the C-C 578 
motif chemokine receptor 1 (CCR1). WLS, which we found to be preferentially expressed in fetal 579 
Sertoli cells, is an important mediator of Wnt secretion (Bänziger et al., 2006; Das et al., 2012), 580 
suggesting a potential role in promoting sex determination. We found CCR1 to be preferentially 581 
expressed in germ cells. This was rather surprising since a sexually-dimorphic expression pattern at 582 





in expression in somatic cells as they commit to their male or female fates. CCR1 encodes a chemokine 584 
receptor thought to be implicated in stem cell niche establishment and maintenance and it has already 585 
been shown to be expressed in postnatal gonocytes in the mouse (Simon et al., 2010). Although we 586 
demonstrated the high quality of the sorted cell populations used in the current study, it cannot be 587 
totally excluded that the germline expression of CCR1 may indeed correspond to a contamination by 588 
KIT-expressing somatic cells such as macrophages. Many other candidate genes display a SOX9-like 589 
expression pattern suggesting that some of them could also be important for Sertoli cell differentiation. 590 
Among these candidate genes, several are already known to be important for gonad development or 591 
fertility in humans and/or mice, such as such as FATE1, MAGEB1 or SOX10. Interestingly, while we 592 
found the expression pattern of SOX10 to be conserved between human and mouse (i.e. with strong 593 
preferential expression in young fetal testes), that of SOX8 was not. Instead, we found SOX8 to be 594 
expressed in a similar manner in human fetal testes and ovaries, with peak expression between 6 and 595 
7 PWC followed by subsequent downregulation. While this expression profile is clearly not 596 
incompatible with a role during early testis differentiation as in the mouse (Schepers et al., 2003), it 597 
also suggests a potential broader involvement in development of both XX and XY gonads in humans. 598 
The role of other candidates, such as the Erb-b2 receptor tyrosine kinase 3 (ERBB3) and the EPH 599 
receptor B1 (EPHB1), remains unknown during early gonad development. The expression of ERBB3 600 
has been reported in mouse PGCs in the genital ridge suggesting that the ErbB signalling might 601 
contribute to control of growth and survival of PGCs (Toyoda-Ohno et al., 1999). The expression of 602 
EPHB1 has never been reported in the fetal testis but is involved in angiogenesis and neural 603 
development (Pasquale, 2005). 604 
Due to the limited number of known markers for distinct fetal ovarian somatic cells, the association of 605 
female-biased expression patterns (P8-P14) with specific cell populations remains challenging at the 606 





are over-expressed in the ovary, compared with the testis, as early as 6 PCW. This is in line with the 608 
fact that PGCs proliferate at a higher rate than somatic cells in the human fetal ovary (Bendsen et al., 609 
2003; Lutterodt et al., 2009; Mamsen et al., 2010). Experimental investigations allowed us to identify 610 
candidate genes associated with the ovarian somatic cell lineages, such as SRY-box 4 (SOX4), SET 611 
nuclear proto-oncogene (SET), contactin 1 (CNTN1), neurexin 3 (NRXN3) and neuropeptide Y (NPY). 612 
This set of genes holds great promise as potential key factors for female sex determination and ovary 613 
differentiation. SOX4 encodes a transcription factor with a high mobility group box domain and its 614 
expression has already been described in supporting cells of the mouse gonads, although without 615 
evident sexual dimorphism (Zhao et al., 2017). SET, for which we demonstrate a highly sexually 616 
dimorphic expression as early as 6 PCW, is implicated in transcriptional regulation through 617 
epigenomic modifications and has been associated with polycystic ovary syndrome (Jiang et al., 2017). 618 
Other candidate genes expressed in somatic cells appear to be implicated in neurogenesis, such as 619 
NRXN3, NPY and CNTN1 (Sutton et al., 1988; Markiewicz et al., 2003; Bizzoca et al., 2012; Harkin 620 
et al., 2016). NRXN3 is expressed at a very weak level in the human fetal brain between 8 and 12 PCW 621 
(Harkin et al., 2016) , i.e. 2 weeks after a high transcriptional induction in the fetal ovary at 6 PCW, 622 
which may indicate an independent role of the gene in both processes. NPY is already known to control 623 
female reproductive processes at the hypothalamus level, and to have a direct action on ovarian cell 624 
proliferation and apoptosis in prepubertal gilts (Sirotkin et al., 2015). In contrast, CNTN1 encodes a 625 
neuronal cell adhesion molecule that has never been described in reproductive-related processes, but 626 
seems to be a key factor in the development of many cancers (Chen et al., 2018). The role of these 627 
three candidates in female developing gonads remains unknown. All of the above mentioned male-628 
biased (WLS, CCR1, ERBB3, EPHB1, CITED1 and asCITED1) and female-biased (SOX4, SET, 629 
NRXN3 and NPY) candidate genes would require further functional experiments to untangle their role 630 





One of the most original contributions of our study is to unravel the non-coding counterpart of the fetal 632 
gonadal transcriptome. To the best of our knowledge, this is the first study to address this issue in 633 
humans. As mentioned before, we assembled 1,209 lncRNAs and 318 NUTs expressed in developing 634 
fetal gonads. The statistical comparison of their genomic features and a protein-encoding analysis 635 
strongly suggest that the vast majority of NUTs corresponds to newly identified lncRNAs. However, 636 
based on the PIT approach and the protein-encoding analyses, a small fraction (6.2%) of the identified 637 
noncoding transcripts are good candidates for novel protein-coding genes as they were confirmed at 638 
the protein level. Our RNA-seq analysis also contributed to the identification of 680 antisense 639 
lncRNAs, including one located on the opposite strand of the Cbp/p300 interacting transactivator with 640 
Glu/Asp rich carboxy-terminal domain 1 (CITED1). Both sense and antisense (asCITED1, 641 
TCONS_00249587) transcripts showed a preferential, highly correlated expression in fetal Sertoli cells 642 
as early as 6 PCW. In the mouse, Cited1 has been reported to be a potential target of Sry (Li et al., 643 
2014) and is specifically expressed in the adult testis (Fagerberg et al., 2014). Our results suggest that 644 
asCITED1 might contribute to the regulation of CITED1, and could therefore be implicated in early 645 
testis development in humans. We also report an accumulation of lncRNAs in expression patterns 646 
associated with female meiosis (P13-P14). This result is line with similar observations that have been 647 
made in adult germ cells from meiosis onwards (Cabili et al., 2011; Laiho et al., 2013; Chalmel et al., 648 
2014; Rolland et al., 2019). This phenomenon thus seems to be conserved in both male and female 649 
germ cells, which suggests that lncRNAs might also play critical roles in human fetal oocytes. 650 
Furthermore, we observed that the vast majority of noncoding early-SDTs (16/20 NUTs, and 28/40 651 
lncRNAs) were preferentially expressed in fetal ovaries, which may reflect a specific non-coding 652 
transcriptional program at play during early ovary development. Further investigation allowed us to 653 
identify that early, female-biased NUTs were preferentially expressed in germ cells 654 





somatic cells (TCONS_00153406 and TCONS_00224470). Additional functional analysis will be 656 
essential to elucidate the role of these germline and somatic candidates in the physiology of the fetal 657 
developing gonads and in the aetiology of DSDs. DSDs indeed comprise heterogeneous conditions 658 
affecting the genital system, with a wide range of phenotypes. The management of these disorders is 659 
globally improved by genetic diagnosis, as it leads to a more accurate prognosis and prediction of the 660 
long-term outcome. Recently, recommendations from the European Cooperation in Science and 661 
Technology state that genetic diagnosis should preferentially use whole exome sequencing of a panel 662 
of candidate genes, while whole genome sequencing should be restricted to suspected oligo- or poly-663 
genic DSDs (Audí et al., 2018). Nevertheless, the majority of genetic testing remains inconclusive as 664 
most causative genes involved in DSDs have not yet been identified (Alhomaidah et al., 2017). 665 
Although many challenges remain to understand the implications of lncRNAs during gonad 666 
development in humans, their functional roles in almost all investigated biological systems are now 667 
supported by several studies (Cheng et al., 2016; Tao et al., 2016), including during gonad 668 
development (Rastetter et al., 2015; Taylor et al., 2015; Winge et al., 2017) and for gonadal functions 669 
(Ohhata et al., 2011; Bao et al., 2013; Taylor et al., 2015; Watanabe et al., 2015; Wen et al., 2016; 670 
Hosono et al., 2017; Wichman et al., 2017; Jégu et al., 2019). Genome-wide association studies of 671 
patients with DSD would therefore greatly benefit from screening for new causal genetic variants in 672 
lncRNAs expressed early in sex determination. In this context our resource will assist geneticists to 673 
refine and complete the required panel of disease candidate genes by including non-coding genes 674 
involved in testicular and ovarian dysgenesis syndromes with a fetal origin, including cryptorchidism 675 
and testicular cancers. 676 
Single-cell technologies now open new avenues for the genomic characterization of biological 677 
systems, including the study of cellular heterogeneity. When compared to bulk approaches, single-cell 678 





fast-evolving field, however, distinct available technologies have specific advantages and limitations, 680 
and may be favoured depending on the scientific question (Baran-Gale et al., 2018). For instance, high-681 
throughput systems that enable the analysis of several thousands of cells, including the mature and 682 
popular droplet-based high-throughput system from 10x Genomics, are needed in order to study 683 
discrete cell populations and/or to accurately reconstruct cell differentiation processes. On the other 684 
hand these systems suffer from a relatively low sensitivity and specificity: they only capture a partial 685 
fraction of the transcriptome of each individual cell (~2-4,000 genes per cell). Furthermore, by 686 
focusing on either the 3’ or the 5’ extremity of RNA molecules, they do not allow the reconstruction 687 
of transcript isoforms or the discovery of new genes. In the near future, increased sensitivity of droplet-688 
based methods, combined with long-read sequencing technologies, will provide accurate transcriptome 689 
information at the isoform level and at a single-cell resolution (Byrne et al., 2019), hopefully at an 690 
affordable price. In the meantime, bulk RNA-seq and current single-cell technologies remain highly 691 
complementary. The current study will support and complement future single-cell experiments aimed 692 
at reconstructing cell lineage progression in fetal gonads. 693 
Overall, our study comprehensively describes the dynamic transcriptional landscape of the fetal gonads 694 
at seven key developmental stages in humans. This work discovered extensive sexually and non-695 
sexually dimorphic expression changes, not only of protein-coding genes but also of lncRNAs and 696 
novel genes that are triggered early during gonad differentiation. This rich resource significantly 697 
extends existing state of the art knowledge and constitutes an invaluable reference atlas for the field of 698 
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Figure legends 1125 
Figure 1 Sample collection and assessment of homogeneity. 1126 
(A) Human fetal gonads used in this study were collected at seven developmental stages, i.e. at 6, early 1127 
7, late 7, 9, 12, 13–14 and 17 postconceptional week (PCW). The number of replicates is indicated for 1128 
each stage and sex. An overview of the main differentiation processes within human fetal testes and 1129 
ovaries during the studied time window is also provided. PGC = primordial germ cell; LC = Leydig 1130 
cell. The panel (B) displays the correlation (R2) of the first 10 dimensions of principal component 1131 
analysis (PCA) with the development stage and the genetic sex. The PCA was performed on expression 1132 
data from 35,194 refined transcripts across all 48 human fetal gonads. Red values represent significant 1133 
correlations (p-value ≤ 1%). (C) A scatter plot represents the position of each sample along the first 1134 
two dimensions. Smaller dots represent samples, and are linked to bigger dots that represent the 1135 
average expression of transcripts across replicates. The histogram represents the percentage of 1136 
information carried by each dimension of the PCA. Testis samples are colored in blue, while ovaries 1137 
are in red. Time point of each condition is provided in PCW. e7 = early 7 PCW; l7 = late 7 PCW. The 1138 
variability between the samples is mainly explained by their age of development (dimension 1) and by 1139 
their genetic sex (dimension 2). The two arrows highlight the divergence of gonads transcriptomes, 1140 
from a common origin (at 6 PCW) to their distinct fate. (D) A dendrogram shows the hierarchical 1141 
relationship between the 48 samples. The hierarchical clustering is based on the 35 first PCA 1142 
dimensions explaining 90% of the total variance of the data. Male samples are colored in blue, female 1143 
samples are in red. (E) Coding potential analysis of refined transcripts. The combined results of the 1144 
Protein-Encoding Potential (PEP) and the Proteomics Informed by Transcriptomic (PIT) strategies, i.e. 1145 
Low or High PEP transcripts with (PIT+) or without (PIT-) identified peptide(s) are represented for 1146 
each transcript biotype. (F) Two statistical filtrations were used to select differentially-expressed 1147 





compared to each other during testis development on the one hand, and during ovarian development 1149 
on the other hand (Fold-change ≥2 in at least one comparison). Second, we performed an “inter-1150 
sex” comparison in which testes and ovaries were compared at each developmental stage (Fold-1151 
change ≥ 2 in at least one comparison). Subsequently, a linear models for microarray data (LIMMA) 1152 
statistical test was performed on both sets of transcripts to select those with significant expression 1153 
variation across replicates [false discovery rate (FDR)-adjusted F-value of ≤ 0.05]. A total of 13,145 1154 
transcripts that display “inter-sex” expression variations were defined as “Sexually dimorphic 1155 
transcripts” (SDT), while 8,935 developmentally-regulated transcripts that do not exhibit sexual 1156 
dimorphism were defined as “Non-sexually dimorphic transcripts” (NSDT). 1157 
  1158 
Figure 2 Sexually dimorphic expression patterns during human gonad development. 1159 
(A) Heatmap representation of 13,145 SDTs, distributed into 14 expression patterns (P1 to P14), across 1160 
seven developmental stages for both testes and ovaries. Each row corresponds to a transcript, and each 1161 
column an experimental condition, i.e. the average of testes or ovaries from a given PCW. The 1162 
standardized abundance of transcripts is color-coded according to the scale bar, red corresponding to 1163 
the highest expression level, blue to the lowest. (B) Repartition of known markers involved in gonad 1164 
differentiation and development within SDT expression patterns. Note that several isoforms of a given 1165 
transcript can be assembled and display distinct expression. (C) Gene ontology (GO) terms found to 1166 
be enriched (BH corrected p-value <0.05) in each expression pattern. (D) Transcript biotypes and 1167 
isoform status proportion in SDT (pie chart) and within each cluster of differentially expressed 1168 
transcripts (barplot). The comparison of the 13,145 SDT with the human reference transcriptome by 1169 
Cuffcompare (Pollier et al., 2013) classified them as known isoform (class code “=”), novel isoforms 1170 





regions (“u”), antisense of known transcripts (class code “x”) or other ambiguous biotypes. Proportion 1172 
of mRNAs, long non-coding (lnc)RNAs and NUTS in SDT clusters is given. Total number of 1173 
transcripts in each cluster is indicated on the right side of the plot. An enrichment analysis using a 1174 
hypergeometric strategy highlighted a significant accumulation of lncRNAs and NUT in the P12, P13 1175 
and P14 cluster (p-value <0.05) compared to their distribution within the 14 SDT clusters. 1176 
 1177 
Figure 3 Non-sexually dimorphic expression patterns during human gonad development. 1178 
(A) Heatmap representation of 8,935 NSDTs, distributed into six expression patterns (Q1 to Q6), 1179 
across seven developmental stages for both testes and ovaries. Each row is a transcript, and each 1180 
column is an experimental condition, i.e. the average of testes or ovaries from a given PCW. The 1181 
standardized abundance of transcripts is color-coded according to the scale bar, red corresponding to 1182 
the highest expression level, blue to the lowest. (B) Repartition of known markers involved in gonad 1183 
differentiation and development within SDT expression patterns. Note that several isoforms of a given 1184 
can be assembled and display distinct expression. (C) GO terms found to be enriched (BH corrected 1185 
p-value <0.05) in each expression pattern. (D) The comparison of the 8,935 NSDT with the human 1186 
reference transcriptome by Cuffcompare (Pollier et al., 2013) classified them as known isoform (class 1187 
code “=”), novel isoforms (class code “j”), novel unannotaed transcripts (NUTs) in intronic regions 1188 
(class code “i”), intergenic regions (“u”), antisense of known transcripts (class code “x”) or other 1189 
ambiguous biotypes. Proportions of mRNAs, lncRNAs and NUTS in NSDT (pie chart) and within 1190 
NSDT clusters are given (barplot). The total number of transcripts in each cluster is indicated on the 1191 
right side of the barplot. An enrichment analysis using a hypergeometric strategy highlighted a 1192 
significant accumulation of lncRNAs and NUTs in Q1 and Q6 clusters (p-value <0.05) compared to 1193 






Figure 4 Cellular investigation of early-SDTs that are over-expressed in fetal testis. 1196 
Expression levels (line graphic) and quantitative RT-PCR (histograms) of genes from expression 1197 
pattern P1 and P2, which exhibit a higher differential expression (A) at 6 PCW, such as sex determining 1198 
region Y (SRY), wntless Wnt ligand secretion mediator (WLS), C-X-C motif chemokine ligand 14 1199 
(CXCL14) and C-C motif chemokine receptor 1 (CCR1), and (B) at 7 PCW, such as SRY-box 9 1200 
(SOX9), SRY-box 10 (SOX10), EPH receptor B1 (EPHB1), MAGE family member B1 (MAGEB1), 1201 
fetal and adult testis expressed 1 (FATE1), erb-b2 receptor tyrosine kinase 3 (ERBB3), Cbp/p300 1202 
interacting transactivator with Glu/Asp rich carboxy-terminal domain 1 (CITED1) and novel 1203 
unannotated transcript antisense of CITED1 (TCONS_00249587). Expression levels from RNA-1204 
sequencing (RNA-seq) as a function of age are depicted as blue lines for the testis and pink lines for 1205 
the ovaries. Each point represents the mean fragments per kilobase of exon model per million reads 1206 
mapped (FPKM) ± SEM of the levels measured in four (12 PCW and younger) and two different 1207 
gonads (13-14 and 17 PCW). Quantitative PCR was performed on the different testicular sorted cell 1208 
populations of germ cells (KIT+, red bars) Sertoli cells (hEpA+, green bars) and other cells (KIT-/ 1209 
hEpA-, grey bars). Each column shows a pool of sorted cells from five fetal (6.9-7.3 PCW) testes. 1210 
Each bar represents the mean ± SEM of the fold change in target gene expression relative to the 1211 
reference genes RPLP0 and RPS20. (D) Representative immunohistochemistry of SOX9, SOX10, 1212 
KIAA1210, EPHB1, MAGEB1 and FATE1 on a 7.1 PCW testis. Arrows indicate germ cells (GC). 1213 
Scale bar: 50 µM. 1214 
 1215 





Expression levels (line graphic) and quantitative RT-PCR (histograms) of genes from expression 1217 
pattern P8 and P9, which exhibit a higher differential expression (A) at 6 PCW, such as Neurexin 3 1218 
(NRXN3), contactin 1 (CNTN1) and SET nuclear proto-oncogene (SET), (B) at 7 PCW, such as R-1219 
spondin 1 (RSPO1), neuropeptide Y (NPY), SRY-box 4 (SOX4) and NUT TCONS_00224470, and (C) 1220 
or later on, as POU class 5 homeobox 1 (POU5F1) and NUTs TCONS_00113718, TCONS_00055038 1221 
and TCONS_00042565. Expression levels from RNA-seq as a function of age are depicted as blue 1222 
lines for the testis and pink lines for the ovaries. Each point represents the mean FPKM ± SEM of the 1223 
levels measured in four (12 PCW and younger) and two different gonads (13-14 and 17 PCW). 1224 
Quantitative RT-PCR was performed on the ovarian sorted cell populations of germ cells (KIT+, pink 1225 
bars) and other cells (KIT-, grey bars). Each column shows a pool of sorted cells from seven early 1226 
differentiating (6.7-8.7 PCW, 7–9 PCW) and three fetal (10.6-11.7 PCW, 10–12 PCW) ovaries. Each 1227 
bar represents the mean ± SEM of the fold change in target gene expression relative to the reference 1228 
genes RPLP0 and RPS20. (D) Immunofluorescence for NRXN3 (green) and KIT (red), LIN28 (green) 1229 
and CNTN1 (red), and WT1 (green) and KIT (red), in early differentiating ovaries (6-6.6 PCW). Scale 1230 
bar: 100 µM. 1231 
 1232 
Supplementary Figure S1 Refinement strategy of assembled transcripts. 1233 
Following transcript reconstruction with Cufflinks, a refinement strategy was performed to discard 1234 
sequencing and assembly artefacts: only transcripts with an expression of ≥ 1 FPKM in at least one 1235 
experimental condition (average value of biological replicates) were considered; transcripts with a 1236 
length of less than 200 nucleotides were discarded; novel transcript isoforms (Cuffcompare class “j”) 1237 
and genes (classes “i”, “u” and “x”) were required to harbor at least two exons. FPKM = fragments per 1238 






Supplementary Figure S2 Genomic and expression features comparison. 1241 
Violin plot representation of selected expression and genomic features for all expressed mRNAs and 1242 
long noncoding (lncRNAs) and novel unannotated transcripts (NUTs): (A) maximum abundance (log), 1243 
(B) Shannon entropy, (C) sequence conservation (phastCons score), (D) cumulative exons size (log), 1244 
(E) number of exons (log), and (F) GC content (%GC). 1245 
 1246 
Supplementary Figure S3 Early sexually dimorphic expression patterns during human gonad 1247 
development. 1248 
(A) Heatmap representation of 1,479 early sexually dimorphic transcripts (early-SDTs), distributed 1249 
into 14 expression patterns (P1 to P14), across seven developmental stages for both testes and ovaries. 1250 
Each row is a transcript, and each column is an experimental condition, i.e. the average of testes or 1251 
ovaries from a given a gestational week (GW). The standardized abundance of transcripts is color-1252 
coded according to the scale bar, red corresponding to the highest expression level, blue to the lowest. 1253 
(B) Repartition of known markers involved in gonad differentiation and development within early-1254 
SDT expression patterns. Note that several isoforms of a given gene can be assembled and display 1255 
distinct expression. (C) Gene ontology (GO) terms found to be enriched (BH corrected p-value <0.05) 1256 
in each expression pattern. (D) The comparison of the 1,479 early-SDT with the human reference 1257 
transcriptome by Cuffcompare (Pollier et al., 2013) classified them as known isoform (class code “=”), 1258 
novel isoforms (class code “j”), novel unannotated transcripts (NUTs) in intronic regions (class code 1259 
“i”), intergenic regions (“u”), antisense of known transcripts (class code “x”) or other ambiguous 1260 





is given (barplot). Total number of transcripts in each cluster is indicated on the right side of the 1262 
barplot. 1263 
 1264 
Supplementary Figure S4 Testicular and ovarian cell-sorting by flow cytometry. 1265 
(A) Representative immunofluorescence of hEpA-FITC (green) staining of cord cells and KIT-PE 1266 
(red) staining of germ cells in testis sections of a 7 PCW old embryo. (B) Representative Side (SSC) 1267 
versus Forward (FSC) scatter plot showing hEpA/Mast/stem cell growth factor receptor Kit (KIT) dot 1268 
plots according to size (FSC-H) and cellular granularity (SSC-H). Example of gating strategy for flow 1269 
cytometry sorting of Sertoli cells (hEpA+/KIT-, green dots), germ cells (hEpA-/KIT+, red plots) and 1270 
other cells types (hEpA-/KIT-, grey plots). (C) Quantitative RT-PCR of KIT proto-oncogene, receptor 1271 
tyrosine kinase (KIT), nuclear receptor subfamily 2 group F member 2 (NR2F2)and SRY-box 1272 
transcription factor 9 (SOX9) was performed on the different sorted cell populations of germ cells 1273 
(KIT+, red bars) Sertoli cells (hEpA+, green bars) and other cells (KIT-/ hEpA-, grey bars). Each 1274 
column shows a pool of sorted cells from five fetal (6.9-7.3 PCW) testes. Each bar represents the mean 1275 
± SEM of the fold change in target gene expression relative to the reference genes ribosomal protein 1276 
lateral stalk subunit P0 (RPLP0) and ribosomal protein S20 (RPS20). (D) Representative 1277 
immunofluorescence of KIT-PE (red) staining of germ cells in sections of an ovary at 11 PCW. (E) 1278 
SSC versus FSC scatter plot showing KIT dot plots according to size (FSC-H) and cellular granularity 1279 
(SSC-H). Example of gating strategy for flow cytometry sorting of germ cells (KIT+, red plots) and 1280 
other cells types (KIT-, grey plots). (F) Quantitative RT-PCR of KIT, NR2F2 and forkhead box L2 1281 
(FOXL2) was performed on the different sorted cell populations of germ cells (KIT+, red bars) and 1282 
other cells (KIT-, grey bars). Each column shows a pool of sorted cells from seven early differentiating 1283 





the mean ± SEM of the fold change in target gene expression relative to the reference genes RPLP0 1285 
and RPS20. Scale bars: 100 µM. 1286 
 1287 
Table legends 1288 
Table I. List of primers that were used for q-PCR experiments. 1289 
Table II. Antibodies used for immunofluorescence and immunohistochemistry. 1290 
Supplementary Table SI. Statistics for read mapping and transcript assembly. 1291 
Supplementary Table SII. Early sexually dimorphic transcripts encoding transcription factors. 1292 































Reverse (5’-3’) Size (bp) Reference
GGTGTTTGGAGTTTCCATCC 80 Primer 3
GTTGTAGGAGAGCCTATTGG 201 PMID:22703800
TGATAACAAGGGTTCCAGTGC 116 PMID: 26855587
TCTCGTTCCAGGCGTTGTAC 148 PMID: 24700803
GGTTTCCCACGGCATCTC 183 PMID: 24121831
GTTGGGCGAATGTTCTCATC 78 PMID: 23991224
CTAGTCTGCGCCACTGCATC 68 PMID: 17761949
CTCGTTGAGGCTGAGGTTGT 75 Primer BLAST
AAATGCTTTCAGGTGCCATC 209 PMID: 21668453
GGTTTCAGCATAGGCTCTCG 130 Primer 3
TCACCACATTGCAGGGTCT 133 PMID: 27722841
AATCTCGTCGGCTGGTTG 131 PMID: 24318875
ATGCTGGCTGTAGAGCGATT 179 PMID: 28013231
CAAAAACCCTGGCACAAACT 131 PMID: 24743772
CAATCTGCAGACAGACACTGG 96 PMID: 24743772
ACGATCCCACGTCTTAGAACC 166 PMID: 24743772
TGCTGAACAGGATGGGAAGAAGGT 146 PMID: 23617070
AAAGAAGCTCTCTGGTTCCTCATG 101 PMID: 22677993
TCCATGTTGGACATTACCTCGT 67 PMID: 23338937
CCGGGCTCGAAGTTAAAATCC 107 PMID: 28535514
TCTCGCTCTCGTTCAGAAGTC 124 Primer3






GAAGCAAATGGAGAGACGGA 111 Primer 3
TTCAGTCCACTCAGCAAACG 138 Primer3
Antigen Heat Induced Epitope Retrieval
hEpA-FITC Mouse FITC-coupled anti-human epithelial antigen -
CNTN1 Contactin 1 Citrate
EPHB1 ephrin type-B receptor 1 Citrate
ERBB3 HER3/ErbB3 (D22C5) XP® Rabbit mAb Citrate
FATE1 fetal and adult testis expressed 1 Citrate
KIAA1210 KIAA1210 Citrate
KIT/CD117-PE mouse R-Phycoerythrin-coupled anti-human KIT/CD117;clone 104D2 -
LIN28 lin-28 homolog A Citrate
MAGEB1 melanoma-associated antigen B1 Citrate
NRXN3 neurexin 3 Citrate
SOX9 SRY (sex determining region Y)-box9 Citrate
SOX10 SRY (sex determining region Y)-box 10 Citrate
WT1 Wilms tumor 1 Citrate
Table II Antibodies used for immunofluorescence and immunohistochemistry.
Dilution Antibody supplier and productnumber
1 :100 Dako, F0860
1 :100 (IF) R&D systems, AF904
1:2500- 1:5000 Sigma, HPA067740 
0.215277778 Cell Signaling Tech., #12708
1:1000-1:2500 Sigma, HPA034604
1:200- 1:500 Sigma, HPA048322
1 :100 BioLegend, 313204
1 :100 (IF) Abcam, Ab46020
1:100 - 1:250 Sigma, HPA001193
1 :200 / 1 :100 (IF) Sigma, HPA0002727
0.111111111 Millipore, AB5535
1:200- 1:500 Sigma, HPA068898
1:100 (IF) Santa-Cruz Biotech, sc-192
Table II Antibodies used for immunofluorescence and immunohistochemistry.
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PGCs proliferation / Oogonia differentiation
Oogonia commitment into meiosis / Arrest in 






Formation of genital ridge
PGCs reach genital ridge
PCW
A. B.








High PEP; PIT+ High PEP; PIT-
Low PEP; PIT+ Low PEP; PIT-




19,456 transcripts (10,422 genes)
LIMMA
F-value(FDR) ≤ 0.05
28,795 transcripts (12,046 genes)20,463 transcripts (9,694 genes)
Inter-sex pairwise comparison
Fold-change ≥ 2







































Stem cell differentiation (6.9e-4)
Reg. of gene expression, epigenetic (1.2e-3)
DNA methylation (5.3e-3)
Mitotic cell cycle (1.3e-5)
ncRNA metabolic process (3.0e-13)
Regulation of translation (1.7e-3)
Histone modification (6.5e-5)






















































Known mRNAs Novel mRNAs
Known lncRNAs Novel lncRNAs
NUTs intergenic (u) NUTs intronic (i)
NUTs antisens (x) Other biotypes
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60,136 long & detectable transcripts
(35,202 genes)
≥ 200 nt
14,739 known isoforms (‘=‘)
(10,899 genes)
41,015 novel isoforms (‘j‘)
or novel genes (‘i’, ‘u’, ‘x’)
(30,392 genes)
20,455 novel multi-exonic transcripts
(10,037 genes)
≥ 2 exons













































































































Neural crest cell differentiation (3.7e-3)
Sex differentiation (2.5e-2)
Steroid biosynthetic process (4.8e-3)
Reg. of neuron differentiation (2.8e-2)










Known mRNAs Novel mRNAs
Known lncRNAs Novel lncRNAs
NUTs intergenic (u) NUTs intronic (i)




































































































































































Supplementary Table SI  Statistics for read mapping and transcript assembly. 
PCW 6 e7 l7 9 12
n° samples 4 4 4 4 4
Average sequenced 50,163,366 43,637,558 45,033,799 44,578,922 61,408,394
pairs of read +- 5 540 241
+- 3 217 
370
+- 4 891 
256 -6124741
 +- 31 392 
665
45,088,608 39,066,943 38,915,843 36,500,690 46,586,645
+-  4 567 
496 +-2 877 937
+- 6 718 
006
+- 3 675 
842
+- 20 642 
653
% of mapped reads 89.9 89.5 86.4 81.9 75.9
n° reconstructed transcripts 164,931 129,802 103,431 116,903 107,148
n° samples 4 4 4 4 4
Average sequenced 51,756,993 42,038,738 43,167,327 45,461,320 43,085,238
pairs of read +- 3 476 980
+- 3 950 
805
+- 6 221 
180
+- 8 410 
709
+- 6 565 
924
46,047,326 38,087,267 33,349,134 37,688,289 34,516,893
+- 3 200 
842 +-3 581 721
+- 3 167 
555
+- 10 017 
251
+- 5 232 
477
% of mapped reads 89 90.6 77.3 82.9 80.1
n° recontructed transcripts 186,499 121,800 93,201 12,817 112,165
n° of non-redundant reconstructed transcripts
Average number of raw and mapped reads, percentage of mapping and number of assembled transcripts are indicated for each experimental condition. 
PCW = post conceptional week. The number of non-redundant assembled transcripts is also provided during testicular and ovarian developments, as well 
as the overall number of non-redundant assembled transcripts in this study.
Average mapped pairs of 
read







+-3 747 882 +- 2 131 643
40,120,429 38,721,188
+- 2 994 
901






+- 3 195 
188
+- 2 869 
127
38,186,847 33,236,072
+- 1 789 
162




180,242n° of non-redundant reconstructed transcripts
Average number of raw and mapped reads, percentage of mapping and number of assembled transcripts are indicated for each experimental condition. 
PCW = post conceptional week. The number of non-redundant assembled transcripts is also provided during testicular and ovarian developments, as well 





Supplementary Table SII  Early sexually dimorphic transcripts encoding transcription factors in human.








































Early sexually dimorphic transcripts (eSDT) corresponding to genes encoding transcription factors (columns A-C), their corresponding expression 
pattern(s) (column D) and their early SDT target genes (column E) are reported. Known interactions between transcription factors and their known 
target genes were extracted from public databases including TRRUST (Han et al. , 2015) and the Transcription Factor encyclopedia (Yusuf et al. , 
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Early sexually dimorphic transcripts (eSDT) corresponding to genes encoding transcription factors (columns A-C), their corresponding expression 
pattern(s) (column D) and their early SDT target genes (column E) are reported. Known interactions between transcription factors and their known 
target genes were extracted from public databases including TRRUST (Han et al. , 2015) and the Transcription Factor encyclopedia (Yusuf et al. , 
















TCONS_00096460;TCONS_00096465 P5;P1 PPARG ;IGFBP3;ES
R1
TCONS_00085918 P7 CCL2
TCONS_00140516;TCONS_00140524 P8 ENPP2
TCONS_00212178 P9 -
TCONS_00024595 P2 -
TCONS_00254399 P8 -
TCONS_00232099;TCONS_00232101 P5;P2 ESR1;ACTG2
TCONS_00246680;TCONS_00246681 P11 -
TCONS_00226393 P8 -
TCONS_00250221 P8 -
TCONS_00080027 P8 -
TCONS_00051081 P2 -
TCONS_00253265 P13 -
TCONS_00048895 P2 -
TCONS_00204519;TCONS_00204520 P9 NANOG;ZFP42
TCONS_00230146 P9 -
TCONS_00149760 P9 CAV1;KLF4;GSTA2
TCONS_00199766;TCONS_00199790 P9 -
TCONS_00075018 P8 -
TCONS_00063928 P1 -
TCONS_00254939 P12 KIT
TCONS_00168163;TCONS_00168164 P8 TAC1;LIN28A;GAB
RB3;KCNQ2
TCONS_00110433 P13 -
TCONS_00101424 P9 -
TCONS_00027617 P9 -
TCONS_00088597 P10 -
TCONS_00140537;TCONS_00140540;TCONS_00140543;TCO
NS_00140544
P9 SALL4;POU5F1
TCONS_00000033;TCONS_00000037 P1 -
TCONS_00056892 P8 -
TCONS_00058144;TCONS_00058145;TCONS_00058146 P8 -
TCONS_00106327;TCONS_00106328;TCONS_00106329 P2;P5 -
TCONS_00061933 P7 -
TCONS_00254705 P2 -
TCONS_00148324;TCONS_00148325 P2 MPZ;PLP1;GJB1;ED
NRB
TCONS_00094642 P2 KLF4;COL2A1;HAP
LN1;COL9A1;PRAM
E;SOX10
TCONS_00098228 P1 -
TCONS_00255818 P1 SOX9;PROM1
TCONS_00145221 P2 -
TCONS_00086893;TCONS_00086894 P2 -
TCONS_00110107;TCONS_00110108;TCONS_00110111 P13;P9 POU5F1
TCONS_00044600 P9 -
TCONS_00137982;TCONS_00137983 P9 ESR1
TCONS_00233028 P5 -
TCONS_00097957 P8 -
TCONS_00025976 P8 -
TCONS_00166063 P9 -
TCONS_00067741 P1 -
TCONS_00104942 P2 -
TCONS_00008281 P6 -
TCONS_00223757 P3 -
TCONS_00112190 P12 -
TCONS_00173057;TCONS_00173058;TCONS_00173059 P8;P9 -
TCONS_00255507;TCONS_00255508;TCONS_00255510 P2;P5 -
TCONS_00158407 P3 -
TCONS_00196743 P10 -
TCONS_00020765 P14 -
TCONS_00140371 P4 -
TCONS_00213671 P8 -
TCONS_00111586;TCONS_00111591 P9 -
TCONS_00083148 P4 -
TCONS_00140595;TCONS_00140597;TCONS_00140603 P9;P8 -
TCONS_00108714 P12 -
TCONS_00095744 P9 -
TCONS_00018508 P1 -
TCONS_00053148 P8 -
TCONS_00253003 P5 -
TCONS_00113462 P8 -
TCONS_00110665 P9 -
TCONS_00112218 P9 -
TCONS_00117137 P9 -
TCONS_00107451 P10 -
TCONS_00111593;TCONS_00111597 P13;P9 -
TCONS_00107534 P9 -
TCONS_00197324 P12 -
TCONS_00107416 P11 -
TCONS_00107411 P10 -
TCONS_00111603 P11 -
